Ethylphenidate or EP or Ethylcaine or Ethyl 2-phenyl-2-piperidin-2-ylacetate or 2-Piperidineacetic acid is a powerful stimulant and an analogue of methylphenidate (Ritalin). Ethylphenidate is a recent research chemical introduced in 2011. Ethylphenidate is a minor metabolite of methylphenidate formed readily in the presence of ethanol. Ethylphenidate is in fact the ethyl ester of 2-phenyl-2-(2-piperidyl) acetic acid, whereas methylphenidate is the methyl ester. Like methylphenidate, ethylphenidate inhibits the reuptake of dopamine and noradrenaline. This leads to an increase in the extracellular concentrations of neurotransmitters in the brain, thereby resulting in an increase in neurotransmission.
Ethylphenidate is the ethyl ester of 2-phenyl-2-(2-piperidyl)acetic acid, in the similar manner that methylphenidate is the methyl ester. Ethylphenidate, which was first identified as a stimulant in the mid 1950s, remains a research chemical and has not been approved for human consumption. As a result, it cannot under any circumstances be used for in vivo testing. We commonly used as a psycho stimulant for the treatment of attention-deficit hyperactivity disorder (ADHD). Most research has been done around the in vivo creation of ethylphenidate by mixing alcohol with methylphenidate. Since the synthetic formulation is novel it is interesting to research the difference between the two ways of experiencing ethylphenidate in the human body. It is a potent psychostimulant that acts as both a dopamine reuptake inhibitor and norepinephrine reuptake inhibitor. Anecdotal evidence suggests it is actually more active as a dopamine reuptake inhibitor than norepinephrine. This produces a less jittery and more euphoric high than methylphenidate. This product is intended only for use as an internal standard for methylphenidate quantitation from biological samples or for biological or pharmacokinetic research studies.